# Theranosis Life Sciences Pvt

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/theranosis-life-sciences-pvt

- Industry: Medical Devices & Equipment
- Headquarters: Hyderabad, India
- Website: www.theranosis.com
- Total disclosed funding: $0.6M
- Latest round: Seed (Mar 7, 2018)
- Investors on record: 3

## About

Theranosis Life Sciences Pvt Ltd specializes in advanced genomic solutions for personalized medicine in oncology, offering innovative genomic analysis services and bioinformatics tools to enhance cancer treatment strategies.Theranosis Life Sciences Pvt Ltd, founded in 2016, operates from its headquarters in Hyderabad, India. The company focuses on genomic solutions for cancer treatment. Shibichakravarthy Kannan, the founder and CEO, has played a pivotal role in its establishment. In March 2018, the company raised INR 35.52 million in Seed funding, led by Mumbai Angels with participation from Omphalos Ventures India and Purple Patch Ventures, bringing the total amount raised to INR 35.52 million and the current valuation to INR 115.118 million.Theranosis Life Sciences Pvt Ltd delivers genomic analysis services and bioinformatics tools aimed at identifying cancer-related genetic variations. Their offerings include advanced genomic sequencing services and software solutions for interpreting genetic data, targeting oncologists, researchers, and pharmaceutical companies seeking to improve cancer treatment through precise genomic profiling. The company operates in North America, Europe, and Asia, serving a diverse clientele that includes academic institutions, hospitals, and biotech firms.In 2016, Theranosis Life Sciences Pvt Ltd generated zero revenue and reported an EBITDA of zero. The company primarily engages in B2B transactions, partnering with healthcare providers and research institutions for genomic analysis, establishing service agreements or subscription models to ensure a steady revenue stream while contributing to advancements in cancer care.Following its Seed funding round in March 2018, Theranosis Life Sciences Pvt Ltd aims to enhance its product offerings and expand geographically. The company plans to launch new genomic analysis tools and is targeting expansion into additional regions in Asia and Europe by 2023. The recent funding of INR 35.52 million will be allocated to support product development and market expansion initiatives.

## Funding rounds

- Seed, Mar 7, 2018, $0.6M — Mumbai Angels, Purple Patch Ventures, Omphalos Ventures India

## Investors

- Mumbai Angels (https://capitalatlas.ai/funds/mumbai-angels) — Seed
- Purple Patch Ventures (https://capitalatlas.ai/funds/purple-patch-ventures) — Seed
- Omphalos Ventures India (https://capitalatlas.ai/funds/omphalos-ventures-india) — Seed